Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: Results from a phase 3, randomised, double-blind withdrawal trial Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Arthritis, Juvenile
  • Maintenance Chemotherapy
  • Receptors, Interleukin-6

abstract

  • NCT00988221.

authors

publication date

  • June 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4431348

Digital Object Identifier (DOI)

  • 10.1136/annrheumdis-2014-205351

PubMed ID

  • 24834925

Additional Document Info

start page

  • 1110

end page

  • 7

volume

  • 74

number

  • 6